{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:45:05Z","timestamp":1791384305583,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.4158\/ep-2017-0251","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T11:56:24Z","timestamp":1521633384000},"page":"361-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Short-Term Sitagliptin-Metformin Therapy Is More Effective Than Metformin Or Placebo In Prior Gestational Diabetic Women With Impaired Glucose Regulation"],"prefix":"10.1016","volume":"24","author":[{"given":"Karen E.","family":"Elkind-Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Shaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh C.","family":"Gutowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 suppl 2","key":"10.4158\/EP-2017-0251_bb0010","doi-asserted-by":"crossref","first-page":"1674S","DOI":"10.1093\/jn\/133.5.1674S","article-title":"Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus","volume":"133","author":"Catalano","year":"2003","journal-title":"J Nutr"},{"key":"10.4158\/EP-2017-0251_bb0015","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1210\/jcem.86.3.7339","article-title":"Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes","volume":"86","author":"Buchanan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0251_bb0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/qjmed\/77.3.1219","article-title":"Abnormalities of glucose tolerance following gestational diabetes","volume":"77","author":"Dornhorst","year":"1990","journal-title":"Q J Med"},{"key":"10.4158\/EP-2017-0251_bb0025","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"10.4158\/EP-2017-0251_bb0030","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1210\/jc.2008-0772","article-title":"Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions","volume":"93","author":"Ratner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0251_bb0035","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1210\/jc.2003-032044","article-title":"Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and \u03b2-cell function","volume":"89","author":"Xiang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0251_bb0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.4158\/EP-2017-0251_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2174\/1389450115666140311102638","article-title":"Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment","volume":"15","author":"Janardhan","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.4158\/EP-2017-0251_bb0050","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","article-title":"Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers","volume":"87","author":"Nauck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0251_bb0055","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/en.2004-0015","article-title":"Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system","volume":"145","author":"Brubaker","year":"2004","journal-title":"Endocrinology"},{"key":"10.4158\/EP-2017-0251_bb0060","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1136\/bmj.e1369","article-title":"Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis","volume":"344","author":"Karagiannis","year":"2012","journal-title":"BMJ"},{"issue":"suppl 1","key":"10.4158\/EP-2017-0251_bb0065","first-page":"4","article-title":"Position statement. Standards of medical care in diabetes-2013","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0251_bb0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2017-0251_bb0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bmj.313.7056.559d","article-title":"Ratio of waist circumference to height is strong predictor of intra-abdominal fat","volume":"313","author":"Ashwell","year":"1996","journal-title":"BMJ"},{"key":"10.4158\/EP-2017-0251_bb0080","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","author":"Elkind-Hirsch","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0251_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.4158\/EP-2017-0251_bb0090","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP-2017-0251_bb0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1464-5491.1995.tb00399.x","article-title":"The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion","volume":"12","author":"Wareham","year":"1995","journal-title":"Diabet Med"},{"key":"10.4158\/EP-2017-0251_bb0100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.4158\/EP-2017-0251_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/eje.0.1500097","article-title":"Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess \u03b2 cell function in clinical studies","volume":"150","author":"Ahr\u00e9n","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2017-0251_bb0110","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/oby.2008.307","article-title":"Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test","volume":"16","author":"Retnakaran","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.4158\/EP-2017-0251_bb0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12020-012-9830-9","article-title":"Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. See comment in PubMed Commons below","volume":"43","author":"Bergman","year":"2013","journal-title":"Endocrine"},{"key":"10.4158\/EP-2017-0251_bb0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/IJWH.S13333","article-title":"Gestational diabetes: risks, management, and treatment options","volume":"2","author":"Kim","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.4158\/EP-2017-0251_bb0125","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2017-0251_bb0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diabres.2005.06.003","article-title":"Waist circumference is the key risk factor for diabetes in Korean women with history of gestational diabetes","volume":"71","author":"Cho","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP-2017-0251_bb0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1463-1326.2006.00698.x","article-title":"Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes","volume":"9","author":"Rosenstock","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP-2017-0251_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.fertnstert.2016.09.023","volume":"107","author":"Elkind-Hirsch","year":"2017","journal-title":"Fertil Steril"},{"key":"10.4158\/EP-2017-0251_bb0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/met.2017.0095","article-title":"Dipeptidyl peptidase-4 inhibitor sitagliptin prevented weight regain in obese women with polycystic ovary syndrome previously treated with liraglutide: a pilot randomized study","volume":"15","author":"Ferjan","year":"2017","journal-title":"Metab Syndr Relat Disord"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20356111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20356111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:05:08Z","timestamp":1761516308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20356111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1530891X20356111"],"URL":"https:\/\/doi.org\/10.4158\/ep-2017-0251","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-Term Sitagliptin-Metformin Therapy Is More Effective Than Metformin Or Placebo In Prior Gestational Diabetic Women With Impaired Glucose Regulation","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2017-0251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}